INVO Fertility, Inc. Common Stock
IVFStock
$1.13−98.81%52W
Market Cap$2.02M
P/E—
Div yield—
Beta2.34
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-83.56%
Price vs S&P 500 (4W)-23.76%
VGM Score49.62
Market Capitalization$2.02M
Earnings Surprise History
Q4 25-196.81est. -2.78
Q1 26-3.38est. -1.26
Analyst Recommendations
Apr 2026
May 2026
Jun 2026
Jul 2026
4.00
4.00
4.00
4.00
Industry Peers — Surgical & Medical Instruments(141)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
IVFINVO Fertility, Inc. Common Stock | B | B | F | $1.13 |
| SYKStryker Corporation | C | C | D | $331.20 |
| MMM3M Company | C | F | B | $161.77 |
| BSXBoston Scientific Corp. | C | B | F | $44.62 |
| MDLNMedline Inc. Class A common stock | C | D | D | $41.11 |
| BDXBecton, Dickinson and Co. | B | C | B | $159.93 |
| DXCMDexCom, Inc. | C | B | C | $77.98 |
| RMDResMed Inc. | C | B | D | $202.76 |
| WSTWest Pharmaceutical Services, Inc. | D | C | A | $362.44 |
| SOLVSolventum Corporation | C | D | B | $81.70 |
| PENPenumbra, Inc. | F | C | B | $319.60 |
About
INVO Fertility Inc. is a healthcare company focused on expanding access to assisted reproductive technology through its proprietary INVOcell medical device, which enables fertilization and early embryo development to occur within the patient's body. The company operates through three revenue-generating segments: clinical services (including its WFI and Atlanta-based clinics), INVOcell device manufacturing and sales, and therapeutics through its acquired subsidiary NTI. This diversified model combines direct patient care with medical device commercialization to address the growing fertility treatment market.